Final Glance: Biotechnology companies
News | 13 June 2012
Final Glance: Biotechnology companies. ... NEW YORK ? Shares of some top biotechnology companies were mixed at the close of trading: Amgen Inc. rose ...
Click on the link to read the full article at CBS News
(This link will open in a new window)
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
